Fighting childhood cancer, one cup at a time.
ALSF funded researchers like Dr. Todd Druley, pictured above, are closer than ever before to finding cures by studying DNA building blocks specific to childhood leukemia.
by Trish Adkins
When a child is first diagnosed with leukemia, the goal is to force the disease into remission. The treatment protocol is long and grueling—at least 2 1/2 years of chemotherapy, lumbar punctures and clinic visits. Today, children diagnosed with the most common form of pediatric leukemia—acute lymphoblastic leukemia (ALL)—have a high cure rate. The discovery of genetic differences that can increase a child’s risk... Read More
CAR T cell immunotherapy could offer promise for many children battling relapsed ALL. ALSF-funded Young Investigator, Dr. Rebecca Gardner at Seattle Children’s Hospital, pictured above, helped a young girl reach remission for her relapsed leukemia.
More and more research is focused on harnessing the body’s immune system to target and destroy cancer cells. One type, known as CAR T cell immunotherapy, is offering new hope and cures to patients with relapsed acute lymphoblastic leukemia (ALL). Here’s everything you need to know about CAR T cell immunotherapy:
What is immunotherapy? Immunotherapy recruits the body’... Read More
Kids are some of the best lemonade stand organizers around. Above, Campbell, Chase and Teagan enjoy the day at their front yard lemonade stand.
by Jeff Baxter, ALSF Community Engagement Manager
The start of our lemonade stand is fast approaching. My girls are running around the house in anticipation of our front yard lemonade stand. My wife and I are gathering the supplies and setting up the stand.
Gone are the days of mixing up one small pitcher of lemonade. We’ve now graduated to bulk containers of lemonade mix and 8-gallon coolers. We know... Read More
